HeavenlyDoor.com Expands Internet Strategy to Include Religious Features; Company Signs Letter of Understanding with Lucoral Co., Inc.

Business Editors

CAMBRIDGE, Mass. and NEW YORK--(BUSINESS WIRE)--Feb. 28, 2000

HeavenlyDoor.com, Inc. (Nasdaq SmallCap:HVDC) and Lucoral Co., Inc. (privately held, a subsidiary of The Lucoral & Lupearl Corporation) today announced that they have signed a letter of understanding which contemplates an alliance that will feature religious jewelry and giftware of the Lucoral Co. ("LCI") on HVDC's website.

HVDC will develop and maintain the website, and process on-line transactions. LCI will direct and assist HVDC in marketing efforts. Sixty (60%) percent of revenues generated from LCI's products will be remitted to LCI in exchange for LCI taking responsibility for all manufacturing and inventory, leaving 40% to be retained by HVDC. HVDC will have an exclusive right to market the products developed or selected for their website for one year. Through its relationships with political and religious leaders, LCI will use its best efforts to provide endorsements, assistance, and support for the HVDC website which is intended to include efforts to broadcast the sermons and speeches of certain religious leaders on the HVDC website.

"This represents a substantial opportunity for HeavenlyDoor.com," comments Mr. John F. Dee, President and Chief Executive Officer of HVDC. "First, religion is a natural fit with our strategy to provide products and services for the elderly, with an initial focus on the pre-planning of funerals." As mentioned on the front page article of the February 25 Wall Street Journal, `baby boomers are thinking about mortality. Just as they revised their parents' vision of the good life, insisting on spiritual and emotional health as well as material success...now they want to personalize and take control of the death experience as well.' Second, this will help us accelerate our e-commerce capabilities. The revenue potential for jewelry and related items on the Internet is very large.

Mr. John Lu, Chairman of The Lucoral & Lupearl Group, stated, "This alliance will help us expand our markets for religious jewelry using the Internet. Our religious product portfolio is a great fit with HeavenlyDoor.com's objectives. We hope this alliance can grow into other areas as well, including the potential development of an Asian website with HeavenlyDoor.com."

The Lucoral & Lupearl Corporation is a privately held international jewelry group and a well respected name in the industry. It specializes in coral, cultured pearls, diamonds, amber, crystals, precious and semi-precious gemstones, and precious metal jewelry. The company employs over 1500 people in 15 offices around the world - the head office in Taipai, Taiwan; an operation office and workshop in New York; six pearl farms in China; a designer studio and workshop in Barcelona; as well as showrooms in Hong Kong, Connecticut, and Japan. The group is among the largest of coral and cultural pearl creators and owns pearl farms in the South China Sea and Pescadores Islands. It has also established a research and design studio and museum in Honolulu, Hawaii. The company has a line of religious jewelry, the gems of which have references in the holy books, and is blessed by certain religious leaders. For additional information, visit their website at http://lupearl.com/English/ehomepage.htm.

HeavenlyDoor.com, Inc., the result of a recent merger between Procept, Inc. (formerly Nasdaq SmallCap: PRCT) and Heaven's Door Corporation, a privately held Internet company, is a publicly held Internet company whose objective is to provide products and services for the elderly and aging baby boomer population, with an initial focus on the pre-planning of funerals, and ultimately the long-term care, assisted living and financial/estate planning industries. The company, through its subsidiary d/b/a Procept, Inc. is developing and seeks to out-license two biotechnology compounds, PRO 2000 Gel and O6-Benzylguanine, both of which have had substantial government support for their clinical trials to date.

Certain statements in this press release constitute "forward-looking statements" that involve risks and uncertainties, including those arising under the Company's business strategy; the ability to enter into relationships with funeral homes and other service and product providers; the market acceptance of the Company's web site; the success of the Company in financing efforts; the pursuit of collaborative arrangements for research and development of product candidates, as well as the pursuit of joint development or licensing arrangements with pharmaceutical, diagnostic or instrumentation companies; the research or development of particular products, compounds or technologies; the uncertainty of the results of such development activities and related clinical trials or required regulatory approvals; and the reliance on collaborative partners and governments for development, regulatory or marketing activities.